{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:52:09Z","timestamp":1793069529995,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-18222"],"award-info":[{"award-number":["A-18222"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-5038"],"award-info":[{"award-number":["A-5038"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64936-4","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:17:38Z","timestamp":1763133458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Suppression of Huntington\u2019s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1988","authenticated-orcid":false,"given":"Ella W.","family":"Mathews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1477-2197","authenticated-orcid":false,"given":"Sydney R.","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-9679","authenticated-orcid":false,"given":"Annette","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2577-2336","authenticated-orcid":false,"given":"Jillian","family":"Belgrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-8954","authenticated-orcid":false,"given":"Robert M.","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-0465","authenticated-orcid":false,"given":"Jeffrey P.","family":"Cantle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6184-3258","authenticated-orcid":false,"given":"Cassandra","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-0457","authenticated-orcid":false,"given":"Ashley","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-1298","authenticated-orcid":false,"given":"Joachim","family":"Fentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Schwagarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5846-957X","authenticated-orcid":false,"given":"Ioannis","family":"Lingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Burch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa A.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Frank","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Kordasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-1064","authenticated-orcid":false,"given":"Deanna M.","family":"Marchionini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-9329","authenticated-orcid":false,"given":"Hilary","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Beuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-2805","authenticated-orcid":false,"given":"Ricardo M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-8071","authenticated-orcid":false,"given":"Anastasia","family":"Khvorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8259-5796","authenticated-orcid":false,"given":"Vanessa C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-8868","authenticated-orcid":false,"given":"Jeffrey B.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"64936_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"64936_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan, P. & Tabrizi, S. J. Huntington\u2019s disease: a clinical review. Eur. J. Neurol. 25, 24\u201334 (2018).","journal-title":"Eur. J. Neurol."},{"key":"64936_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew, S. E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat. Genet. 4, 398\u2013403 (1993).","journal-title":"Nat. Genet."},{"key":"64936_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat. Genet. 4, 387\u2013392 (1993).","journal-title":"Nat. Genet."},{"key":"64936_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell, R. G. et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat. Genet. 4, 393\u2013397 (1993).","journal-title":"Nat. Genet."},{"key":"64936_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"G Consortium","year":"2015","unstructured":"Consortium, G. M. of H. D. (GeM-H. et al. Identification of genetic factors that modify clinical onset of huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"64936_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius, H. et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet. 6, 409\u2013414 (1994).","journal-title":"Nat. Genet."},{"key":"64936_CR8","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/9.17.2539","volume":"9","author":"L Kennedy","year":"2000","unstructured":"Kennedy, L. & Shelbourne, P. F. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington\u2019s disease? Hum. Mol. Genet 9, 2539\u20132544 (2000).","journal-title":"Hum. Mol. Genet"},{"key":"64936_CR9","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet 12, 3359\u20133367 (2003).","journal-title":"Hum. Mol. Genet"},{"key":"64936_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler, V. C. et al. Length-dependent gametic CAG repeat instability in the huntington\u2019s disease knock-in mouse. Hum. Mol. Genet. 8, 115\u2013122 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"64936_CR11","doi-asserted-by":"publisher","first-page":"e44273","DOI":"10.1371\/journal.pone.0044273","volume":"7","author":"M Kovalenko","year":"2012","unstructured":"Kovalenko, M. et al. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in huntington\u2019s disease knock-in mice. PLoS ONE 7, e44273 (2012).","journal-title":"PLoS ONE"},{"key":"64936_CR12","doi-asserted-by":"crossref","unstructured":"Handsaker, R. E. et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease. Cell 188, 623\u2212639.e19 (2024)","DOI":"10.1016\/j.cell.2024.11.038"},{"key":"64936_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41588-024-01653-6","volume":"56","author":"K M\u00e4tlik","year":"2024","unstructured":"M\u00e4tlik, K. et al. Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum. Nat. Genet. 56, 383\u2013394 (2024).","journal-title":"Nat. Genet."},{"key":"64936_CR14","unstructured":"Consortium, G. M. of H. D. (GeM-H. et al. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington\u2019s Disease Onset. Cell 178, 887\u2212900.e14 (2019)."},{"key":"64936_CR15","doi-asserted-by":"publisher","unstructured":"Consortium, G. M. of H. D. (GeM-H. et al. Genetic modifiers of somatic expansion and clinical phenotypes in Huntington\u2019s disease reveal shared and tissue-specific effects. bioRxiv https:\/\/doi.org\/10.1101\/2024.06.10.597797.(2024).","DOI":"10.1101\/2024.06.10.597797"},{"key":"64936_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","volume":"104","author":"GEB Wright","year":"2019","unstructured":"Wright, G. E. B. et al. Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of huntington disease. Am. J. Hum. Genet. 104, 1116\u20131126 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"64936_CR17","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1371\/journal.pcbi.0030235","volume":"3","author":"S Kaplan","year":"2007","unstructured":"Kaplan, S., Itzkovitz, S. & Shapiro, E. A universal mechanism ties genotype to phenotype in trinucleotide diseases. PLoS Comput. Biol. 3, e235 (2007).","journal-title":"PLoS Comput. Biol."},{"key":"64936_CR18","doi-asserted-by":"publisher","first-page":"e1003930","DOI":"10.1371\/journal.pgen.1003930","volume":"9","author":"RM Pinto","year":"2013","unstructured":"Pinto, R. M. et al. Mismatch repair genes Mlh1 and Mlh3 modify cag instability in huntington\u2019s disease mice: genome-wide and candidate approaches. Plos Genet 9, e1003930 (2013).","journal-title":"Plos Genet"},{"key":"64936_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","volume":"33","author":"E Dragileva","year":"2009","unstructured":"Dragileva, E. et al. Intergenerational and striatal CAG repeat instability in Huntington\u2019s disease knock-in mice involve different DNA repair genes. Neurobiol. Dis. 33, 37\u201347 (2009).","journal-title":"Neurobiol. Dis."},{"key":"64936_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/hmg\/ddg056","volume":"12","author":"VC Wheeler","year":"2003","unstructured":"Wheeler, V. C. et al. Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum. Hum. Mol. Genet 12, 273\u2013281 (2003).","journal-title":"Hum. Mol. Genet"},{"key":"64936_CR21","doi-asserted-by":"publisher","unstructured":"Wang, N. et al. Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice. bioRxiv https:\/\/doi.org\/10.1101\/2024.07.09.602815.(2024).","DOI":"10.1101\/2024.07.09.602815"},{"key":"64936_CR22","doi-asserted-by":"crossref","unstructured":"Aldous, G et al. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington\u2019s disease. Brain. 147, 1784\u20131798 (2024)","DOI":"10.1093\/brain\/awae063"},{"key":"64936_CR23","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl. Acad. Sci. USA 110, 2366\u20132370 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64936_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD Gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"64936_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/hmg\/ddu504","volume":"24","author":"BA Barbaro","year":"2015","unstructured":"Barbaro, B. A. et al. Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington\u2019s disease. Hum. Mol. Genet 24, 913\u2013925 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"64936_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J., Ghosh, R. & Leavitt, B. R. Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron 101, 801\u2013819 (2019).","journal-title":"Neuron"},{"key":"64936_CR27","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting Huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"64936_CR28","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMc2300400","volume":"389","author":"P McColgan","year":"2023","unstructured":"McColgan, P. et al. Tominersen in adults with manifest Huntington\u2019s disease. N. Engl. J. Med. 389, 2203\u20132205 (2023).","journal-title":"N. Engl. J. Med."},{"key":"64936_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27157-z","volume":"12","author":"A Bhattacharyya","year":"2021","unstructured":"Bhattacharyya, A. et al. Small molecule splicing modifiers with systemic HTT-lowering activity. Nat. Commun. 12, 7299 (2021).","journal-title":"Nat. Commun."},{"key":"64936_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","volume":"25","author":"B Zeitler","year":"2019","unstructured":"Zeitler, B. et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease. Nat. Med 25, 1131\u20131142 (2019).","journal-title":"Nat. Med"},{"key":"64936_CR31","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the huntington disease gene \/ allele-specific silencing of mutant Huntingtin. Mol. Ther. 19, 2178\u20132185 (2011).","journal-title":"Mol. Ther."},{"key":"64936_CR32","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/mt.2014.153","volume":"22","author":"AL Southwell","year":"2014","unstructured":"Southwell, A. L. et al. In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides. Mol. Ther. 22, 2093\u20132106 (2014).","journal-title":"Mol. Ther."},{"key":"64936_CR33","doi-asserted-by":"publisher","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","volume":"9","author":"NH Skotte","year":"2014","unstructured":"Skotte, N. H. et al. Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all huntington disease patients. PLoS ONE 9, e107434 (2014).","journal-title":"PLoS ONE"},{"key":"64936_CR34","doi-asserted-by":"publisher","first-page":"e161769","DOI":"10.1172\/jci.insight.161769","volume":"7","author":"DM Marchionini","year":"2022","unstructured":"Marchionini, D. M. et al. Benefits of global mutant huntingtin lowering diminish over time in a Huntington\u2019s disease mouse model. JCI Insight 7, e161769 (2022).","journal-title":"JCI Insight"},{"key":"64936_CR35","doi-asserted-by":"publisher","first-page":"e0175968","DOI":"10.1371\/journal.pone.0175968","volume":"12","author":"SR Coffey","year":"2017","unstructured":"Coffey, S. R. et al. Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111\/+ mouse model of Huntington\u2019s disease. Plos One 12, e0175968 (2017).","journal-title":"Plos One"},{"key":"64936_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-4-29","volume":"4","author":"J-M Lee","year":"2010","unstructured":"Lee, J.-M. et al. A novel approach to investigate tissue-specific trinucleotide repeat instability. Bmc Syst. Biol. 4, 29 (2010).","journal-title":"Bmc Syst. Biol."},{"key":"64936_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke, S. T., Baker, B. F., Crooke, R. M. & Liang, X. Antisense technology: an overview and prospectus. Nat. Rev. Drug Discov. 20, 427\u2013453 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64936_CR38","doi-asserted-by":"crossref","unstructured":"Lai, F., Damle, S. S., Ling, K. K. & Rigo, F. Directed RNase H Cleavage of nascent transcripts causes transcription terminationn. Mol. Cell 77, 1032\u22121043.e4 (2020)","DOI":"10.1016\/j.molcel.2019.12.029"},{"key":"64936_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.molcel.2019.12.011","volume":"77","author":"J-S Lee","year":"2020","unstructured":"Lee, J.-S. & Mendell, J. T. Antisense-mediated transcript knockdown triggers premature transcription termination. Mol. Cell 77, 1044\u20131054.e3 (2020).","journal-title":"Mol. Cell"},{"key":"64936_CR40","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.cell.2022.04.031","volume":"185","author":"LE Marasco","year":"2022","unstructured":"Marasco, L. E. et al. Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy. Cell 185, 2057\u20132070.e15 (2022).","journal-title":"Cell"},{"key":"64936_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/hmg\/ddq501","volume":"20","author":"M Nakamori","year":"2011","unstructured":"Nakamori, M., Pearson, C. E. & Thornton, C. A. Bidirectional transcription stimulates expansion and contraction of expanded (CTG)\u2022(CAG) repeats. Hum. Mol. Genet. 20, 580\u2013588 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"64936_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47485-0","volume":"15","author":"ZL McLean","year":"2024","unstructured":"McLean, Z. L. et al. Splice modulators target PMS1 to reduce somatic expansion of the Huntington\u2019s disease-associated CAG repeat. Nat. Commun. 15, 3182 (2024).","journal-title":"Nat. Commun."},{"key":"64936_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymeth.2019.01.003","volume":"155","author":"WS Lai","year":"2019","unstructured":"Lai, W. S., Arvola, R. M., Goldstrohm, A. C. & Blackshear, P. J. Inhibiting transcription in cultured metazoan cells with actinomycin D to monitor mRNA turnover. Methods 155, 77\u201387 (2019).","journal-title":"Methods"},{"key":"64936_CR44","doi-asserted-by":"publisher","first-page":"106313","DOI":"10.1016\/j.nbd.2023.106313","volume":"187","author":"K Shing","year":"2023","unstructured":"Shing, K. et al. Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model. Neurobiol. Dis. 187, 106313 (2023).","journal-title":"Neurobiol. Dis."},{"key":"64936_CR45","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1101\/gad.892001","volume":"15","author":"CA Cronin","year":"2001","unstructured":"Cronin, C. A., Gluba, W. & Scrable, H. The lac operator-repressor system is functional in the mouse. Genes Dev. 15, 1506\u20131517 (2001).","journal-title":"Genes Dev."},{"key":"64936_CR46","doi-asserted-by":"publisher","first-page":"41570","DOI":"10.1038\/srep41570","volume":"7","author":"RM Bragg","year":"2017","unstructured":"Bragg, R. M. et al. Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt\/+Q111\/+ model of Huntington\u2019s disease. Sci. Rep.-uk 7, 41570 (2017).","journal-title":"Sci. Rep.-uk"},{"key":"64936_CR47","doi-asserted-by":"publisher","first-page":"e23647","DOI":"10.1371\/journal.pone.0023647","volume":"6","author":"JM Lee","year":"2011","unstructured":"Lee, J. M., Pinto, R. M., Gillis, T., St Claire, J. C. & Wheeler, V. C. Quantification of age-dependent somatic CAG repeat instability in Hdh CAG Knock-In mice reveals different expansion dynamics in striatum and liver. PLoS ONE 6, e23647 (2011).","journal-title":"PLoS ONE"},{"key":"64936_CR48","doi-asserted-by":"crossref","unstructured":"Thomson, S. B. & Leavitt, B. R. Transcriptional Regulation of the Huntingtin Gene. J. Huntingt.\u2019s Dis. 7, 289\u2212296 (2018).","DOI":"10.3233\/JHD-180331"},{"key":"64936_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30480-8","volume":"13","author":"M Kosicki","year":"2022","unstructured":"Kosicki, M. et al. Cas9-induced large deletions and small indels are controlled in a convergent fashion. Nat. Commun. 13, 3422 (2022).","journal-title":"Nat. Commun."},{"key":"64936_CR50","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1111\/febs.12735","volume":"281","author":"J Zhou","year":"2014","unstructured":"Zhou, J. et al. Dual sgRNAs facilitate CRISPR\/Cas9-mediated mouse genome targeting. FEBS J. 281, 1717\u20131725 (2014).","journal-title":"FEBS J."},{"key":"64936_CR51","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"G-P Gao","year":"2002","unstructured":"Gao, G.-P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854\u201311859 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64936_CR52","doi-asserted-by":"publisher","first-page":"174178","DOI":"10.1016\/j.ejphar.2021.174178","volume":"905","author":"W Alshaer","year":"2021","unstructured":"Alshaer, W. et al. siRNA: Mechanism of action, challenges, and therapeutic approaches. Eur. J. Pharmacol. 905, 174178 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"64936_CR53","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1038\/mtna.2015.38","volume":"4","author":"JF Alterman","year":"2015","unstructured":"Alterman, J. F. et al. Hydrophobically modified siRNAs silence Huntingtin mRNA in primary neurons and mouse brain. Mol. Ther. - Nucleic Acids 4, e266 (2015).","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"64936_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"M Duyao","year":"1995","unstructured":"Duyao, M. et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269, 407\u2013410 (1995).","journal-title":"Science"},{"key":"64936_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","volume":"11","author":"VC Wheeler","year":"2002","unstructured":"Wheeler, V. C. et al. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum. Mol. Genet. 11, 633\u2013640 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"64936_CR56","doi-asserted-by":"crossref","unstructured":"Smith, E. J. et al. Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches. Brain Commun. 5, fcad010 (2023).","DOI":"10.1093\/braincomms\/fcad010"},{"key":"64936_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JHD-200438","volume":"10","author":"RR Iyer","year":"2021","unstructured":"Iyer, R. R. & Pluciennik, A. DNA mismatch repair and its role in Huntington\u2019s disease. J. Huntington\u2019s Dis. 10, 75\u201394 (2021).","journal-title":"J. Huntington\u2019s Dis."},{"key":"64936_CR58","doi-asserted-by":"publisher","first-page":"e1223580","DOI":"10.1080\/21675511.2016.1223580","volume":"4","author":"S Yang","year":"2016","unstructured":"Yang, S., Li, X.-J. & Li, S. Molecular mechanisms underlying spinocerebellar ataxia 17 (SCA17) pathogenesis. Rare Dis. 4, e1223580 (2016).","journal-title":"Rare Dis."},{"key":"64936_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/B978-0-444-63233-3.00011-7","volume":"147","author":"CA Stoyas","year":"2018","unstructured":"Stoyas, C. A. & Spada, A. R. L. Chapter 11 The CAG\u2013polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology. Handb. Clin. Neurol. 147, 143\u2013170 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"64936_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JHD-200426","volume":"10","author":"VC Wheeler","year":"2021","unstructured":"Wheeler, V. C. & Dion, V. Modifiers of CAG\/CTG repeat instability: insights from mammalian models. J. Huntington\u2019s Dis. 10, 123\u2013148 (2021).","journal-title":"J. Huntington\u2019s Dis."},{"key":"64936_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-200423","volume":"10","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. Modifiers of somatic repeat instability in mouse models of friedreich ataxia and the fragile x-related disorders: implications for the mechanism of somatic expansion in huntington\u2019s disease. J. Huntington\u2019s Dis. 10, 149\u2013163 (2021).","journal-title":"J. Huntington\u2019s Dis."},{"key":"64936_CR62","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"AJMH Verkerk","year":"1991","unstructured":"Verkerk, A. J. M. H. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905\u2013914 (1991).","journal-title":"Cell"},{"key":"64936_CR63","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1093\/hmg\/ddu213","volume":"23","author":"RA Lokanga","year":"2014","unstructured":"Lokanga, R. A., Zhao, X.-N., Entezam, A. & Usdin, K. X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the fragile X-related disorders: implications for the mechanism of repeat expansion. Hum. Mol. Genet 23, 4985\u20134994 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"64936_CR64","doi-asserted-by":"publisher","first-page":"e1003051","DOI":"10.1371\/journal.pgen.1003051","volume":"8","author":"A-V Goula","year":"2012","unstructured":"Goula, A.-V. et al. Transcription elongation and tissue-specific somatic CAG instability. Plos Genet 8, e1003051 (2012).","journal-title":"Plos Genet"},{"key":"64936_CR65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat. Genet 15, 197\u2013200 (1997).","journal-title":"Nat. Genet"},{"key":"64936_CR66","doi-asserted-by":"publisher","unstructured":"Pinto, R. M. et al. Identification of genetic modifiers of Huntington\u2019s disease somatic CAG repeat instability by in vivo CRISPR-Cas9 genome editing. bioRxiv https:\/\/doi.org\/10.1101\/2024.06.08.597823.(2024).","DOI":"10.1101\/2024.06.08.597823"},{"key":"64936_CR67","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly, D. et al. Di-valent siRNA mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington\u2019s disease. Mol. Ther. 31, 1661\u22121674 (2023).","DOI":"10.1016\/j.ymthe.2023.05.006"},{"key":"64936_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41588-019-0575-8","volume":"52","author":"M Nakamori","year":"2020","unstructured":"Nakamori, M. et al. A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo. Nat. Genet 52, 146\u2013159 (2020).","journal-title":"Nat. Genet"},{"key":"64936_CR69","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajhg.2024.04.015","volume":"111","author":"R Ferguson","year":"2024","unstructured":"Ferguson, R., Goold, R., Coupland, L., Flower, M. & Tabrizi, S. J. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease. Am. J. Hum. Genet. 111, 1165\u20131183 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"64936_CR70","doi-asserted-by":"publisher","first-page":"eadn4600","DOI":"10.1126\/scitranslmed.adn4600","volume":"17","author":"EL Bunting","year":"2025","unstructured":"Bunting, E. L. et al. Antisense oligonucleotide\u2013mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington\u2019s disease iPSC\u2013derived striatal neurons. Sci. Transl. Med. 17, eadn4600 (2025).","journal-title":"Sci. Transl. Med."},{"key":"64936_CR71","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1523\/JNEUROSCI.3446-10.2011","volume":"31","author":"A Saavedra","year":"2011","unstructured":"Saavedra, A. et al. Striatal-enriched protein tyrosine phosphatase expression and activity in huntington\u2019s disease: a step in the resistance to excitotoxicity. J. Neurosci. 31, 8150\u20138162 (2011).","journal-title":"J. Neurosci."},{"key":"64936_CR72","doi-asserted-by":"publisher","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","volume":"9","author":"D Macdonald","year":"2014","unstructured":"Macdonald, D. et al. Quantification Assays for Total and Polyglutamine-Expanded Huntingtin Proteins. PLoS ONE 9, e96854 (2014).","journal-title":"PLoS ONE"},{"key":"64936_CR73","doi-asserted-by":"publisher","first-page":"e0213521","DOI":"10.1371\/journal.pone.0213521","volume":"14","author":"W Reindl","year":"2019","unstructured":"Reindl, W. et al. Meso scale discovery-based assays for the detection of aggregated huntingtin. PLoS ONE 14, e0213521 (2019).","journal-title":"PLoS ONE"},{"key":"64936_CR74","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao, X., Huang, X., Zhou, Z. & Lin, X. An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat. Bioinform. Biomath. 3, 71\u201385 (2013).","journal-title":"Biostat. Bioinform. Biomath."},{"key":"64936_CR75","unstructured":"Figures created in BioRender: Mathews, E. Figure 1a: https:\/\/BioRender.com\/vywob5f, Fig. 1g: https:\/\/BioRender.com\/4zsnx39, Fig. 2b: https:\/\/BioRender.com\/0z169br, Fig. 3a: https:\/\/BioRender.com\/qmyac2a, Fig. 4a: https:\/\/BioRender.com\/yrqi4w6, Fig. 6a: https:\/\/BioRender.com\/x9uip8x, Fig. 6b: https:\/\/BioRender.com\/yt45a5b. (2025)."},{"key":"64936_CR76","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64936-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:03:41Z","timestamp":1763510621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64936-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64936"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64936-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.04.619693","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G., J.F., T.S., A.C., I.L. are employees of Evotec, and may have stock options. C.F.B. and H.K. Are full time employees at, and hold shares in, Ionis Pharmaceuticals. V.C.W. was a founding scientific advisory board member with a financial interest in Triplet Therapeutics Inc., her financial interests were reviewed and are managed by Massachusetts General Hospital (MGH) and Mass General Brigham (MGB) in accordance with their conflict of interest policies. V.C.W. is a scientific advisory board member of LoQus23 Therapeutics Ltd. and has provided paid consulting services to Acadia Pharmaceuticals Inc., Alnylam Inc., Biogen Inc., Passage Bio and Rgenta Therapeutics and has received research support from Pfizer Inc. J.B.C. has provided paid consulting and\/or conducted sponsored research for Wave Life Sciences, Skyhawk Therapeutics, Cajal Neuroscience, Ionis Pharmaceuticals, Alnylam, and Guidepoint. D.H., D.M., P.B., and T.V.are full-time employees of CHDI Foundation. A.K. discloses ownership of stocks in RXi Pharmaceuticals and Advirna, and is a founder of Atalanta Therapeutics and Comanche Biopharma. R.B. received consulting fees from Takeda. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10009"}}